scholarly journals Evaluation of Subclinical Organ Damage for Risk Assessment and Treatment in the Hypertensive Patient: Role of Microalbuminuria

2006 ◽  
Vol 17 (4 suppl 2) ◽  
pp. S112-S114 ◽  
Author(s):  
Roberto Pontremoli ◽  
Giovanna Leoncini ◽  
Francesca Viazzi ◽  
Elena Ratto ◽  
Valentina Vaccaro ◽  
...  
Keyword(s):  
Risk Assessment ◽  
Hypertensive Patient ◽  
Organ Damage ◽  
Patient Role ◽  
Assessment And Treatment

scholarly journals Psychodynamic approaches to suicide and self-harm

2018 ◽  
Vol 24 (1) ◽  
pp. 37-45
Author(s):  
Jessica Yakeley ◽  
William Burbridge-James
Keyword(s):  
Risk Assessment ◽  
Suicide Attempts ◽  
List Type ◽  
Relational Context ◽  
Transference And Countertransference ◽  
Assessment And Treatment ◽  
Self Harm ◽  
Psychoanalytic Theories ◽  
Risk Assessment And Management

SUMMARYRates of suicide and self-harm are rising in many countries, and it is therapeutically important to explore the personal stories and relationships that underlie this behaviour. In this article psychoanalytic and psychodynamic principles and concepts in relation to violence towards the self are introduced and the various unconscious meanings of suicide and self-harm are explored within a relational context and attachment framework. We describe how a psychodynamic approach may enhance the risk assessment and treatment of patients presenting with self-harm and suicidality, particularly examining the role of transference and countertransference within the therapeutic relationship.LEARNING OBJECTIVES•Understand historical and contemporary psychoanalytic theories and concepts regarding the aetiology of suicide and self-harm•Understand the different meanings and expressions of acts of suicide and self-harm•Understand the use of countertransference in the risk assessment and management of self-harm and suicide attemptsDECLARATION OF INTERESTNone.

scholarly journals Role of Biomarkers in the Diagnosis, Risk Assessment, and Management of Pulmonary Hypertension

2016 ◽  
Vol 11 ◽  
pp. BMI.S38323 ◽  
Author(s):  
Vanessa Rameh ◽  
Antoine Kossaify
Keyword(s):  
Risk Assessment ◽  
Pulmonary Hypertension ◽  
Organ Damage ◽  
Right Heart ◽  
Severe Condition ◽  
Pulmonary Arterial ◽  
Risk Assessment And Management ◽  
Valuable Role ◽  
Different Levels

Pulmonary hypertension is a severe and debilitating disease with no definite cure, and the domain of targeted therapies is a promising field for better management of this severe condition. The disease comprises pulmonary arterial remodeling, hypoxia, endothelial dysfunction, and inflammation, with subsequent organ damage including right heart and liver dysfunction. Biomarkers have a valuable role at different levels of the disease, from diagnosis to risk assessment and management, in order to decrease the burden of the disease in terms of both morbidity and mortality.

The role of omentin in inflammation and metabolic syndrome risk assessment in women with PCO-S

2019 ◽  
Author(s):  
Iwona Zieleń-Zynek ◽  
Joanna Kowalska ◽  
Nowak Justyna ◽  
Barbara Zubelewicz-Szkodzińska
Keyword(s):  
Risk Assessment ◽  
Metabolic Syndrome

Out of sight out of mind: The role of vision in risk assessment and venom metering in Vaejovis carolinianus

Toxicon ◽  
2020 ◽  
Vol 182 ◽  
pp. S33-S34
Author(s):  
C. Lee ◽  
B. Park ◽  
J. Tsai ◽  
D. Carter ◽  
D. Nelsen ◽  
...  
Keyword(s):  
Risk Assessment

Role of Fok I VDR polymorphism in TB risk assessment; A Study in Central India population

Meta Gene ◽  
2021 ◽  
Vol 29 ◽  
pp. 100896
Author(s):  
M. Tiwari ◽  
M.K. Verma ◽  
P.K. Singh ◽  
D. Bharti
Keyword(s):  
Risk Assessment ◽  
Central India ◽  
Vdr Polymorphism

scholarly journals Role of combining anticoagulant and antiplatelet agents in COVID-19 treatment: a rapid review

Open Heart ◽  
2021 ◽  
Vol 8 (1) ◽  
pp. e001628
Author(s):  
Kamal Matli ◽  
Raymond Farah ◽  
Mario Maalouf ◽  
Nibal Chamoun ◽  
Christy Costanian ◽  
...  
Keyword(s):  
Treatment Guidelines ◽  
Anticoagulation Therapy ◽  
Antiplatelet Agents ◽  
Organ Damage ◽  
Multiple Organ ◽  
Rapid Review ◽  
Thromboembolic Events ◽  
Antithrombotic Agent ◽  
Heparin Resistance

Although primarily affecting the respiratory system, COVID-19 causes multiple organ damage. One of its grave consequences is a prothrombotic state that manifests as thrombotic, microthrombotic and thromboembolic events. Therefore, understanding the effect of antiplatelet and anticoagulation therapy in the context of COVID-19 treatment is important. The aim of this rapid review was to highlight the role of thrombosis in COVID-19 and to provide new insights on the use of antithrombotic therapy in its management. A rapid systematic review was performed using preferred reporting items for systematic reviews. Papers published in English on antithrombotic agent use and COVID-19 complications were eligible. Results showed that the use of anticoagulants increased survival and reduced thromboembolic events in patients. However, despite the use of anticoagulants, patients still suffered thrombotic events likely due to heparin resistance. Data on antiplatelet use in combination with anticoagulants in the setting of COVID-19 are quite scarce. Current side effects of anticoagulation therapy emphasise the need to update treatment guidelines. In this rapid review, we address a possible modulatory role of antiplatelet and anticoagulant combination against COVID-19 pathogenesis. This combination may be an effective form of adjuvant therapy against COVID-19 infection. However, further studies are needed to elucidate potential risks and benefits associated with this combination.

Sign in / Sign up

Export Citation Format

Share Document